Tag: Lomustine

Since 2013, the cost of the chemotherapy drug lomustine, branded as Gleostine, has increased by over 1,400%, creating a significant financial burden for many brain cancer patients. This dramatic price hike and its impact on patient access are central to understanding what is the price of lomustine Gleostine and the high cost of this medication.

In 2021, manufacturer list prices for dose levels of Gleostine (lomustine) ranged from $90 to over $1,000 per capsule, leading to average patient costs of $1,500 to $3,000 every six weeks. The question of how much does Gleostine cost reveals a complex landscape of single-source manufacturing, lack of generic availability, and limited insurance coverage. This guide explains the reasons for the high cost and outlines potential avenues for financial relief.